NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)

National Institutes of Health
Deadline: Aug 17, 2026

Description

The NIH Common Fund supports exceptionally creative early-stage investigators pursuing bold, high-impact biomedical or behavioral research without requiring preliminary data.

Eligibility

Early Stage Investigators proposing unusually innovative, high-impact work relevant to the NIH mission; single principal investigator and at least 25 percent research effort required.

Keywords

Funding Amount

Up to $2,375,000

Active — accepting applications

Apply on official site

Grant Details

Contact Information

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.